Mysore Petro Chemicals Ltd

Mysore Petro has experienced fluctuating financial performance, with net sales increasing from 18.41 Cr in Mar'23 to 33.48 Cr in Mar'25, but facing negative operating profits and declining profits after tax, resulting in ongoing operational challenges despite positive cash flow from investing activities.

As of 10-Nov, Mysore Petro Chemicals Ltd's stock price is Rs 106.00, down 1.9% and has fallen 7.99% over the past week, nearing its 52-week low. The stock has significantly underperformed with a year-to-date decline of 30.26% and is trading below key moving averages, reflecting negative investor sentiment.

As of 04-Nov, Mysore Petro Chemicals Ltd's stock price is Rs. 111.50, down 3.21%, and has reached a 52-week low of Rs. 110, indicating significant downward pressure and underperformance compared to its sector and the broader market. The stock has declined 41.49% over the past year and 26.64% year-to-date, with a notable drop in investor participation.

As of 24-Sep, Mysore Petro Chemicals Ltd's stock price is Rs 115.50, down 3.71%, and has underperformed significantly, declining 24.01% year-to-date compared to a 4.58% gain in the Sensex. The stock is trading below all major moving averages and is close to its 52-week low, indicating a bearish trend and reduced investor participation.

As of 18-Sep, Mysore Petro Chemicals Ltd's stock price is Rs 119.75, down 1.2%, and has significantly underperformed with a year-to-date decline of 21.22%. The company faces operating losses and a dramatic drop in delivery volume, indicating weak investor interest and long-term financial challenges.

As of 16-Sep, Mysore Petro Chemicals Ltd is priced at 119.25, with a recent slight increase but a year-to-date decline of 21.55%. The stock has underperformed its sector and the broader market over the long term, despite a slight outperformance in the past month.

As of 15-Sep, Mysore Petro Chemicals Ltd's stock price is Rs 119.15, up 3.16% after three days of decline, but it faces significant long-term challenges including operating losses and a 21.61% year-to-date decline, indicating ongoing financial pressure despite short-term gains.

As of 12-Sep, Mysore Petro Chemicals Ltd's stock price is Rs 115.50, down 3.02% and has declined 5.79% over the last three days. The stock is trading below all major moving averages, indicating a bearish trend, and has underperformed compared to the Sensex, which has gained 1.48% in the same period.

As of 11-Sep, Mysore Petro Chemicals Ltd's stock price is Rs 119.10, down 1.08%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with a significant drop in delivery volume and a year-to-date decline of 21.64% compared to the Sensex's rise of 4.36%.

As of 08-Sep, Mysore Petro Chemicals Ltd's stock price is Rs 118.75, down 1.45%, and has underperformed its sector and the Sensex significantly. The company faces substantial operating losses, declining sales, and weak financial metrics, indicating it is a risky investment.

As of 29-Aug, Mysore Petro Chemicals Ltd is seeing a short-term price increase to Rs 119.10, but it has a year-to-date decline of 21.64% and faces significant financial challenges, including operating losses and negative EBITDA. Despite recent gains, the long-term outlook remains concerning due to weak fundamentals.

As of 28-Aug, Mysore Petro Chemicals Ltd is priced at Rs 117.10, having recently reached a 52-week low of Rs 111.2. The stock has shown a negative trend with a year-to-date drop of 22.96% and significant operational challenges, including losses and declining sales, indicating weak long-term fundamentals.

As of 26-Aug, Mysore Petro Chemicals Ltd's stock price is Rs 117.00, down 1.6%, and has been declining for two days. The company faces significant operating losses and a poor long-term outlook, with a -49.82% return over the past year, despite slight short-term outperformance compared to the Sensex.

As of 25-Aug, Mysore Petro Chemicals Ltd's stock price is declining at 118.90, with a bearish trend indicated by trading below key moving averages and a significant drop in investor participation. Despite a short-term return outperforming the Sensex, the company's long-term financial health is weak, marked by substantial losses and negative EBITDA, making it a risky investment.